<?xml version="1.0" encoding="UTF-8"?>
<ref id="B145-pharmaceutics-13-00327">
 <label>145.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Costa</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Cury</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Cassettari</surname>
    <given-names>B.O.</given-names>
   </name>
   <name>
    <surname>Takahira</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Florio</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Costa</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>
   <italic>Citrus aurantium</italic> L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment
  </article-title>
  <source>BMC Complement. Altern. Med.</source>
  <year>2013</year>
  <volume>13</volume>
  <elocation-id>42</elocation-id>
  <pub-id pub-id-type="doi">10.1186/1472-6882-13-42</pub-id>
  <?supplied-pmid 23432968?>
  <pub-id pub-id-type="pmid">23432968</pub-id>
 </element-citation>
</ref>
